BUSINESSWIRE: The results of phase 2 (there are three) trials of a new drug that reduces testosterone to castrate levels and serum free testosterone to levels lower than orchiectomy or LHRH analogs – without bone loss or hot flashes- are about to be reported in the US. READ MORE>
Posts Tagged ‘BUSINESSWIRE’
Results soon of phase two trials of new testosterone-lowering drug
Posted in Testosterone treatment, tagged advanced prostate cancer, Bone loss, BUSINESSWIRE, cancer research, castrate level, catheter, comparison of treatments, GTx-758, hot flashes, LHRH analogs, orchiectomy, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate treatment, prostate treatment debate on August 15, 2010| Leave a Comment »
First minimally invasive surgery to remove prostate via ‘natural orifice’
Posted in PROSTATE CANCER, Treatment news, tagged BUSINESSWIRE, cancer research, catheter, first-of-its-kind surgery, Mayo Clinic in Arizona, minimally invasive surgery, natural orifices, new surgical procedure, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, surgery on July 31, 2010| Leave a Comment »
BUSINESSWIRE: With a recent first-of-its-kind surgery, physicians at Mayo Clinic in Arizona have developed a new surgical procedure for the treatment of prostate cancer using natural orifices – signalling the next step in the evolution of minimally invasive surgery. READ MORE>
Prostablog 